Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2008

Sep 01 2008

Related Content

New Alzheimer's Disease Target and a Potentially Broad Drug Discovery Approach

Jun 01 2008

A Recipe for Acquisition: the Esperion Strategy

Jan 01 2004

Pfizer's Serenex Acquisition Adds Fuel to Heat Shock Fire

Mar 01 2008

Takeda/ Millennium: The Price is Right

Apr 01 2008

Esperion, Again: Pfizer's First Spin-Out's Familiar Look

May 01 2008

Sirtris Satisfies GSK's M&A Appetite

May 01 2008

Promedior and Stromedix Spot Fresh Approaches in Fibrosis

May 01 2008

Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way

Jun 01 2008

Takeda's Global Ambition

Jun 01 2008

New Avenues towards Biotech Exits? Not Just Yet.

Jul 01 2008

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2007

Sep 01 2007

Related Companies

Apogenix AG

Stromedix, Inc.

Biogen, Inc.

U.S. Stem Cell, Inc.

AGC Biologics SPA

Aldagen, Inc.

Duke University School of Medicine

Johns Hopkins University

Codexis, Inc.

Antisoma plc

Astellas Pharma, Inc.

Array BioPharma, Inc.

ZymoGenetics

Bristol Myers Squibb Company

Mead Johnson Nutrition Co.

ConvaTec Group PLC

Pfizer Inc.

Esperion Therapeutics, Inc.

Enzon Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Daiichi Sankyo Co., Ltd.

U3 Pharma AG

MorphoSys AG

Ranbaxy Laboratories Limited

Novartis AG

Novartis AG

Sanofi

Zentiva Group a.s.

GSK plc

Sirtris Pharmaceuticals

Roche Holding AG

CoMentis, Inc.

Additional Topics

BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window